Literature DB >> 9026476

Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis.

T Sakagami1, M Dixon, J O'Rourke, R Howlett, F Alderuccio, J Vella, T Shimoyama, A Lee.   

Abstract

BACKGROUND/AIMS: The role of host factors has been neglected in studies of the pathogenesis of Helicobacter associated disease. The aim of this study was to assess the response of different mouse strains to infection with a single strain of Helicobacter felis.
METHOD: Six strains of inbred mice were infected with the identical H felis culture and were killed at one month, two months, and six months after infection to assess histopathological changes. In addition, two strains of mice were infected with a mouse adapted strain of H pylori and examined at six months after infection.
RESULTS: In SJL, C3H/He, DBA/2, and C57BL/6 infected mice, severe to moderate chronic active gastritis was observed only in the body of the stomach, which increased in severity over time with specialised cells in the body glands being replaced. As the severity of this damage in the body increased and atrophic changes were seen, the level of bacterial colonisation of the antrum decreased. In contrast, in BALB/c and CBA mice, there was only mild gastritis in the antrum, no remarkable changes were detected in their body mucosa, and no atrophy was seen over time. In both these strains of mice, heavy bacterial colonisation was seen, which tended to increase over the period of the experiment. Of particular importance in this experiment was that bacterial colonisation was mainly restricted to the antrum yet the atrophy, when present, was only observed in the body of the stomach. H pylori infected C3H/He mice showed moderate colonisation of the antrum, which persisted up to six months with little development of atrophy. In contrast, H pylori in C57BL/6 mice showed excellent colonisation of the antrum at two months but six months after infection there was moderate to severe body atrophy, which was associated with a loss of bacteria from the antrum.
CONCLUSIONS: These findings challenge current concepts of the development of Helicobacter induced atrophy in that active chronic gastritis of antrum or the body mucosa, or both, is not a prerequisite. They also suggest an autoimmune basis for the pathology although no autoantibody or antibody to the H+/K+ ATPase was detected. Loss of infecting helicobacters from the stomach together with development of an atrophic gastritis in the body of the stomach is similar to the pattern found in certain H pylori infected human subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9026476      PMCID: PMC1383385          DOI: 10.1136/gut.39.5.639

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Diagnostic ELISA for parietal cell autoantibody using tomato lectin-purified gastric H+/K(+)-ATPase (proton pump).

Authors:  J S Chuang; J M Callaghan; P A Gleeson; B H Toh
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

2.  Helicobacter pylori infection and atrophic gastritis in the elderly.

Authors:  M A Faisal; R M Russell; I M Samloff; P R Holt
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

3.  Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach.

Authors:  F A Karlsson; P Burman; L Lööf; S Mårdh
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  A correlative study of immunological phenomena in pernicious anaemia.

Authors:  R G Strickland; S Baur; L A Ashworth; K B Taylor
Journal:  Clin Exp Immunol       Date:  1971-01       Impact factor: 4.330

5.  Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa.

Authors:  R Negrini; L Lisato; I Zanella; L Cavazzini; S Gullini; V Villanacci; C Poiesi; A Albertini; S Ghielmi
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

6.  Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis.

Authors:  W E Karnes; I M Samloff; M Siurala; M Kekki; P Sipponen; S W Kim; J H Walsh
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

7.  Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity.

Authors:  B J Appelmelk; I Simoons-Smit; R Negrini; A P Moran; G O Aspinall; J G Forte; T De Vries; H Quan; T Verboom; J J Maaskant; P Ghiara; E J Kuipers; E Bloemena; T M Tadema; R R Townsend; K Tyagarajan; J M Crothers; M A Monteiro; A Savio; J De Graaff
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

8.  Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production.

Authors:  M K Tummuru; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa.

Authors:  M Siurala; P Sipponen; M Kekki
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

View more
  65 in total

1.  Genetic factors determining the host response to Helicobacter pylori.

Authors:  AS Pena
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Molecular mechanisms of H. pylori associated gastric carcinogenesis.

Authors:  Zun-Wu Zhang; Michael JG Farthing
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

3.  Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.

Authors:  M F Dixon
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

4.  Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands.

Authors:  I T Padol; R H Hunt
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

5.  Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats.

Authors:  K W Simpson; D Strauss-Ayali; E Scanziani; R K Straubinger; P L McDonough; A F Straubinger; Y F Chang; C Domeneghini; N Arebi; J Calam
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

6.  Mouse Models Of Helicobacter Infection And Gastric Pathologies.

Authors:  Kimberley D'Costa; Michelle Chonwerawong; Le Son Tran; Richard L Ferrero
Journal:  J Vis Exp       Date:  2018-10-18       Impact factor: 1.355

7.  Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.

Authors:  Yong Xie; Nan-Jin Zhou; Yan-Feng Gong; Xiao-Jiang Zhou; Jiang Chen; Si-Juan Hu; Nong-Hua Lu; Xiao-Hua Hou
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

8.  Suppressed Gastric Mucosal TGF-beta1 Increases Susceptibility to H. pylori-Induced Gastric Inflammation and Ulceration: A Stupid Host Defense Response.

Authors:  Yunjeong Jo; Sang Uk Han; Yoon Jae Kim; Ju Hyeon Kim; Shin Tae Kim; Seong-Jin Kim; Ki-Baik Hahm
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 9.  Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.

Authors:  Lin Ding; Mohamad El Zaatari; Juanita L Merchant
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

10.  Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Lievin; E Hemery; A L Servin
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.